Ligand validation:3PJE

TCL: TRICLOSAN

TCL is a Ligand Of Interest in 3PJE designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3PJE_TCL_A_801	68%	22%	0.122	0.934	2.2	1.23	10	3	0	0	100%	1
3PJE_TCL_B_802	59%	21%	0.141	0.924	2.17	1.3	9	4	0	0	100%	1
3PJD_TCL_B_802	66%	20%	0.138	0.945	2.32	1.27	10	4	0	0	100%	1
3PJF_TCL_A_502	52%	28%	0.16	0.92	2.11	0.94	6	2	0	0	100%	0.75
4NR0_TCL_A_302	99%	59%	0.051	0.986	0.8	0.77	1	-	0	0	100%	1
2WYW_TCL_B_1260	99%	33%	0.054	0.982	1.71	1.05	4	-	3	0	100%	1
3OID_TCL_A_601	96%	16%	0.069	0.98	1.65	2.23	3	9	0	0	100%	1
4M89_TCL_A_302	95%	40%	0.065	0.971	1.57	0.85	2	-	1	0	100%	1
1D7O_TCL_A_502	95%	44%	0.074	0.98	1.36	0.87	2	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.